Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-06

Clinical Trial Update: Real World Glycemic Effectiveness of Linagliptin

View source ↗

Summary

A completed real-world study evaluating the glycemic effectiveness of linagliptin in type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linagliptin (linagliptin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2019-05-06